These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
807 related articles for article (PubMed ID: 12404782)
21. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam]. Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC Encephale; 1984; 10(3):135-8. PubMed ID: 6389091 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of a putative anxiolytic agent: ipsapirone. Borison RL; Albrecht JW; Diamond BI Psychopharmacol Bull; 1990; 26(2):207-10. PubMed ID: 1978371 [TBL] [Abstract][Full Text] [Related]
23. [A new generation of tranquilizing agents]. Escande M; Frexinos M; Fabre S Rev Prat; 1994 Nov; 44(17):2316-9. PubMed ID: 7984939 [TBL] [Abstract][Full Text] [Related]
28. [Open clinical study of the efficacy and safety of Halazepam in anxiety disorders]. Lozano ; Crespo ; O'Neil ; Pelegrín ; De Pablo ; Bayas ; Díaz ; Viñas ; Moreno Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1990; 18(4):205-11. PubMed ID: 1981637 [TBL] [Abstract][Full Text] [Related]
29. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. Castaneda AE; Tuulio-Henriksson A; Marttunen M; Suvisaari J; Lönnqvist J J Affect Disord; 2008 Feb; 106(1-2):1-27. PubMed ID: 17707915 [TBL] [Abstract][Full Text] [Related]
30. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety]. Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD Encephale; 1991; 17(4):295-300. PubMed ID: 1959498 [TBL] [Abstract][Full Text] [Related]
31. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study. Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501 [TBL] [Abstract][Full Text] [Related]
32. [Clinical evaluation of oxypertine in anxiety conditions]. Somohano MD; Broissin MC; Sobrino Z A Neurol Neurocir Psiquiatr; 1976; 17(3):171-80. PubMed ID: 12484 [TBL] [Abstract][Full Text] [Related]
33. Buspirone in the long-term treatment of generalized anxiety disorder. Feighner JP J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034 [TBL] [Abstract][Full Text] [Related]
35. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam. Klein E J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116 [TBL] [Abstract][Full Text] [Related]
40. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]